ELV

ELV

USD

Elevance Health Inc. Common Stock

$316.620+6.160 (1.984%)

실시간 가격

Healthcare
Healthcare Plans
미국

가격 차트

Loading Chart...

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$310.460

고가

$318.790

저가

$310.000

거래량

0.89M

기업 기본 정보

시가총액

70.4B

산업

Healthcare Plans

국가

United States

거래 통계

평균 거래량

1.99M

거래소

NYQ

통화

USD

52주 범위

저가 $273.71현재가 $316.620고가 $458.75

관련 뉴스

Analyst Upgrades

Mizuho Maintains Outperform on Elevance Health, Lowers Price Target to $400

Mizuho analyst Ann Hynes maintains Elevance Health with a Outperform and lowers the price target from $420 to $400.

더 보기
Mizuho Maintains Outperform on Elevance Health, Lowers Price Target to $400
Analyst Upgrades

JP Morgan Maintains Overweight on Elevance Health, Raises Price Target to $394

JP Morgan analyst Lisa Gill maintains Elevance Health with a Overweight and raises the price target from $384 to $394.

더 보기
JP Morgan Maintains Overweight on Elevance Health, Raises Price Target to $394
Analyst Upgrades

TD Cowen Maintains Buy on Elevance Health, Raises Price Target to $380

TD Cowen analyst Ryan Langston maintains Elevance Health with a Buy and raises the price target from $330 to $380.

더 보기
TD Cowen Maintains Buy on Elevance Health, Raises Price Target to $380
Analyst Upgrades

Wells Fargo Maintains Overweight on Elevance Health, Lowers Price Target to $403

Wells Fargo analyst Stephen Baxter maintains Elevance Health with a Overweight and lowers the price target from $412 to $403.

더 보기
Wells Fargo Maintains Overweight on Elevance Health, Lowers Price Target to $403
Reuters

Elevance beats profit estimates as health insurer keeps costs in check

Elevance Health on Tuesday beat Wall Street estimates for third-quarter profit as the health insurer managed to keep medical costs in check, sending its shares 3% higher in premarket trading.

더 보기
Elevance beats profit estimates as health insurer keeps costs in check
Analyst Upgrades

Morgan Stanley Maintains Equal-Weight on Elevance Health, Raises Price Target to $359

Morgan Stanley analyst Erin Wright maintains Elevance Health with a Equal-Weight and raises the price target from $316 to $359.

Analyst Upgrades

Goldman Sachs Initiates Coverage On Elevance Health with Neutral Rating, Announces Price Target of $343

Goldman Sachs analyst Scott Fidel initiates coverage on Elevance Health with a Neutral rating and announces Price Target of $343.

최신 정보 받기

가격 알림 설정, AI 분석 업데이트 및 실시간 시장 뉴스 받기